Furthermore, the number of Iba1 positive stained microglia cells and GFAP positive stained astroglia cells in the CA1 region and the DG in AAV-CPE treated AD mice were reduced compared to untreated AD mice (Figure S5K, L, Figure S6). This evidence concerns the gene GFAP and Alzheimer disease.